Benign Prostatic Hyperplasia Devices Market

Table of Contents

1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology
    2.1 Research Methodology Steps
    2.2 Secondary and Primary Research Methodology
           2.2.1 Secondary Research
           2.2.2 Primary Research
                    2.2.2.1 Key Data From Primary Sources
                    2.2.2.2 Key Insights From Primary Sources
                    2.2.2.3 Key Industry Insights
    2.3 Market Size Estimation Methodology
    2.4 Research Design
    2.5 Market Data Validation and Triangulation
    2.6 Assumptions for the Study

3 Executive Summary

4 Premium Insights

5 Market Overview
    5.1 Introduction
    5.2 Market Segmentation
    5.3 Market Dynamics
           5.3.1 Drivers
           5.3.2 Restraints
           5.3.3 Opportunities

6 Benign Prostatic Hyperplasia Devices Market, By Procedure Type
    6.1 Introduction
    6.2 Transurethral Resection of the Prostate (TURP)
    6.3 Transurethral Microwave Therapy (TUMT)
    6.4 Transurethral Needle Ablation of the Prostate (TUNA)
    6.5 Laser Surgery
    6.6 Prostatic Stenting
    6.7 Other Procedure Type

*Note: Other Procedure Types Include Water-Induced Thermotherapy, High-Intensity Frequency Ultrasound, and Open Prostatectomy

7 Benign Prostatic Hyperplasia Devices Market, By End User
    7.1 Introduction
    7.2 Hospitals and Clinics
    7.3 Ambulatory Surgical Centers (ASC)
    7.4 Home
    7.5 Other End Users

8 Global Benign Prostatic Hyperplasia Devices Market, By Region
    8.1 Introduction
    8.2 North America
           8.2.1 U.S.
           8.2.2 Canada
    8.3 Europe
           8.3.1 Germany
           8.3.1 France
           8.3.1 U.K.
           8.3.2 Rest of Europe (Roe)
    8.4 Asia-Pacific88
           8.4.1 China
           8.4.2 Japan
           8.4.3 India
           8.4.4 Roapac
    8.5 Row

9 Competitive Landscape
    9.1 Overview
    9.2 Competitive Situation and Trends
           9.2.1 Agreements, Collaborations, and Partnerships
           9.2.2 Product Launches
           9.2.3 Client Acquisitions
           9.2.4 Expansions
           9.2.5 Acquisitions
           9.2.6 Other Strategies

10 Company Profiles
(Overview, Financial*, Products & Services, Strategy, and Developments)
     10.1 Introduction
     10.2 Endo International Plc
     10.3 Karl Storz Gmbh & Co.Kg
     10.4 Lumenis
     10.5 Olympus Corporation
     10.6 Urologix, Inc.
     10.7 Boston Scientific Corporation
     10.8 Coloplast A/S
     10.9 Lisa Laser
     10.10 Medifocus, Inc.
     10.11 Neotract, Inc.
     10.12 Proarc Medical Ltd.
     10.13 Urotech Gmbh

*Details Might Not Be Captured in Case of Unlisted Companies.

11 Appendix
     11.1 Insights of Industry Experts
     11.2 Discussion Guide
     11.3 Company Developments (2013–2016)
     11.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
     11.5 Introducing RT: Real-Time Market Intelligence
     11.6 Available Customizations
     11.7 Related Reports

Note:
1. All the Above Markets Will Be Provided for the Years 2014, 2015, 2016, and 2021
2. Revenue for Companies Listed Under “Company Profile” Section (Chapter 10) Might Not Be Captured for Companies Whose Financial Data is Not Available in Public Domain
3. the Above Scope is Tentative and is Subject to Change as the Research Progresses